Strumento inattivo

Altre lingue Heron Therapeutics Inc OTC Bulletin Board

Azioni

APPAD

US4277461020

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product under the Proposed 2025 Non-Opioid Policy for Pain Relief under the OPPS and the ASC Payment System	16/07
Heron Therapeutics Says Non-Opioid Pain Medication to be Included in Proposed Medicare Programs	15/07
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System	15/07
Heron Therapeutics, Inc. Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System	15/07
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle	02/07
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")	02/07
Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle	02/07
Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index	24/06
Connect Biopharma Names New Chief Executive, Chair	12/06
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle	29/05
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	29/05
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	29/05
Heron Therapeutics : Investor Day Presentation	15/05
Heron Therapeutics: Q1 Earnings Snapshot	07/05
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	07/05
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates	07/05
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	24/04
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City	11/04
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference	28/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Heron Therapeutics Inc OTC Bulletin Board

Azioni

APPAD

US4277461020

Altre lingue

Filtri